hims glp-1 dosage chart A new era of weight management is coming to & Hers. In partnership with Novo Nordisk, Hims & Hers will soon offer access to the only FDA-approved weight loss pill Weight Loss Care for Men,

Are there alternative treatment options

Lixisenatide (Adlyxin) Adlyxin received FDA approval on July 27, 2016 as a once daily GLP 1 agonist

Medicare Part D coverage of semaglutide for cardiovascular risk reduction expanded in 2024 following SELECT trial results

This suggests we may be able to decouple cardiometabolic benefit from weight loss entirely

Dosing ranges from 0.25 mg to 2.4 mg weekly for semaglutide, 0.75 mg to 4.5 mg weekly for dulaglutide, and 0.6 mg to 3 mg daily for liraglutide, with your healthcare provider determining the optimal dose based on glycemic control, tolerability, renal function, and cardiovascular risk factors

Hear how a patient transformed their weight and overall health with our personalized medical weight loss program